How It Works
SLU-PP-332 is a small-molecule agonist of ERRα, a nuclear receptor that regulates mitochondrial biogenesis, oxidative phosphorylation, and fatty acid metabolism. By activating ERRα, it mimics the transcriptional changes caused by exercise, including increased expression of genes involved in fat burning and muscle fiber type switching.
Common Research Protocols
Research Dosing Range
Supplied as 250 mcg oral capsules (60 per bottle). As an emerging research compound, established human protocols are limited. Preclinical studies used daily oral dosing. Researchers typically start at 1 capsule daily and assess. This is a very new compound — consult the latest literature for updated guidance.
Use our free dosing calculator to determine exact syringe units after reconstitution.
Reconstitution Guide
Follow these steps to properly reconstitute SLU-PP-332 for research use:
- Step 1: Swab the tops of both the peptide vial and bacteriostatic water vial with alcohol.
- Step 2: Draw your desired amount of BAC water (commonly 1–2 mL) into an insulin syringe.
- Step 3: Inject the water slowly into the peptide vial, aiming at the glass wall — not directly onto the powder.
- Step 4: Swirl the vial gently until fully dissolved — never shake.
- Step 5: Refrigerate at 36–46°F (2–8°C). Use within 4–6 weeks.
Use the dosing calculator to calculate your exact concentration (mcg per unit) and how many units to draw on your syringe.
Frequently Asked Questions
How does SLU-PP-332 work? ▾
SLU-PP-332 is a small-molecule agonist of ERRα, a nuclear receptor that regulates mitochondrial biogenesis, oxidative phosphorylation, and fatty acid metabolism. By activating ERRα, it mimics the transcriptional changes caused by exercise, including increased expression of genes involved in fat burning and muscle fiber type switching.
What are the key research findings? ▾
- Increased running endurance by ~50% in mouse models without exercise training
- Promoted a shift toward fatigue-resistant slow-twitch muscle fibers
- Enhanced fat oxidation and reduced body weight in preclinical studies
- Represents a new class of "exercise mimetic" compounds
What is the typical dosing protocol? ▾
Supplied as 250 mcg oral capsules (60 per bottle). As an emerging research compound, established human protocols are limited. Preclinical studies used daily oral dosing. Researchers typically start at 1 capsule daily and assess. This is a very new compound — consult the latest literature for updated guidance.
How should SLU-PP-332 be stored? ▾
Unreconstituted powder should be stored in a freezer or refrigerator away from light and moisture. Once reconstituted with bacteriostatic water, refrigerate at 36–46°F (2–8°C) and use within 4–6 weeks. Never freeze reconstituted peptides.